Detect the undetectable: Newly developed test allows to screen for the presence of drugs based on drug activity

“Looks don’t matter, it’s what you do that counts.” This quote from Skipper, from “Penguins of Madagascar” is the general theme throughout the work of Annelies Cannaert, a Ph.D. student at the Laboratory of Toxicology at Ghent University, Belgium. Annelies, who will defend her Ph.D. thesis on May 25th, developed a novel concept to detect so-called ‘designer drugs.” Rather than being based on a compound’s structure, as conventional methods do, the alternative concept utilizes a compound’s activity. This makes it possible to screen for the presence of drugs, even without knowing a drug’s identity.